Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 18,817 shares at $117.15 ($2.2M) on 2021-01-08, disclosed to the SEC on 2021-01-12.
Open-market sale of $2.2M FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.76 | 151 | $17K | 0.8% |
| 2 | $115.80 | 872 | $101K | 4.7% |
| 3 | $115.80 | 872 | $101K | 4.7% |
| 4 | $117.15 | 2,451 | $287K | 13.3% |
| 5 | $117.15 | 2,451 | $287K | 13.3% |
| 6 | $117.60 | 2,756 |
| $324K |
| 15.0% |
| 7 | $117.60 | 2,756 | $324K | 15.0% |
| 8 | $109.65 | 871 | $96K | 4.4% |
| 9 | $109.65 | 871 | $96K | 4.4% |
| 10 | $110.76 | 1,051 | $116K | 5.4% |
| 11 | $110.76 | 1,051 | $116K | 5.4% |
| 12 | $111.62 | 1,332 | $149K | 6.9% |
| 13 | $111.62 | 1,332 | $149K | 6.9% |
| Total | $114.95 avg | 18,817 | $2.2M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |